These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1225170)

  • 1. [Actinomadura cremea var. rifamycini, a producer of rifamycin O].
    Gauze GF; Preobrazhenskaia TP; Lavrova NV; Ukholina RS; Kochetkova NV
    Antibiotiki; 1975 Nov; 20(11):963-6. PubMed ID: 1225170
    [No Abstract]   [Full Text] [Related]  

  • 2. [New species of Actinomadura recticatena sp. nov. and its antibiotic properties].
    Gauze GF; Terekhova LP; Galatenko OA; Preobrazhenskaia TP; Borisova VN
    Antibiotiki; 1984 Jan; 29(1):3-7. PubMed ID: 6696399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways.
    Stratmann A; Schupp T; Toupet C; Schilling W; Oberer L; Traber R
    J Antibiot (Tokyo); 2002 Apr; 55(4):396-406. PubMed ID: 12061548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of rifamycin SV by Amycolatopsis mediterranei MTCC17 in solid cultures.
    Krishna PS; Venkateswarlu G; Pandey A; Rao LV
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):311-5. PubMed ID: 12546705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production of active mutants of a new species of rifamycin producer resistant to specific actinophage].
    Lapchinskaia OA; Zhunaeva VV; Pogozheva VV; Trutneva EM; Filicheva VA
    Antibiotiki; 1975 May; 20(5):393-7. PubMed ID: 1225186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of uracil on rifamycin SV production by Amycolatopsis mediterranei MV35R.
    Murali Krishna PS; Venkateswarlu G; Venkateswar Rao L
    Lett Appl Microbiol; 2000 Jul; 31(1):73-6. PubMed ID: 10886619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultrastructure of the mycelium and spores of Actinomadura fastidiosa sp. nov].
    Soina VS; Sokolov AA; Agre NS
    Mikrobiologiia; 1975; 44(5):883-7. PubMed ID: 1207505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cybernetic model to predict the effect of freely available nitrogen substrate on rifamycin B production in complex media.
    Bapat PM; Sohoni SV; Moses TA; Wangikar PP
    Appl Microbiol Biotechnol; 2006 Oct; 72(4):662-70. PubMed ID: 16534611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New species of Actinomadura coeruleoviolacea sp. nov. and its antagonistic properties].
    Preobrazhenskaia TP; Terekhova LP; Laĭko AV; Selezneva TI; Zenkova VA
    Antibiotiki; 1976 Sep; 21(9):779-84. PubMed ID: 999259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation.
    Bapat PM; Bhartiya S; Venkatesh KV; Wangikar PP
    Biotechnol Bioeng; 2006 Mar; 93(4):779-90. PubMed ID: 16302259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening.
    Jin ZH; Lin JP; Xu ZN; Cen PL
    J Gen Appl Microbiol; 2002 Dec; 48(6):329-34. PubMed ID: 12682871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of low molecular weight regulators on the biosynthesis of rifamycin B by Amycolatopsis mediterranei strains].
    Bushueva OA; Efremenkova OV; Gorin SE; Bartoshevich IuE
    Antibiot Khimioter; 1991 Mar; 36(3):11-5. PubMed ID: 1877868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach.
    Bapat PM; Wangikar PP
    Biotechnol Bioeng; 2004 Apr; 86(2):201-8. PubMed ID: 15052640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Actinomyces tumemacerans Krass., Kov., 1962, var. griseoarenicolor var. nov.--producer of the new tetraene antibiotic arenomycin B].
    Tsyganov VA; Shenin IuD; Solov'ev VN
    Antibiotiki; 1973 Nov; 18(11):973-7. PubMed ID: 4787726
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifamycin R, a novel metabolite from a mutant of Nocardia mediterranea.
    Martinelli E; Antonini P; Cricchio R; Lancini G; White RJ
    J Antibiot (Tokyo); 1978 Oct; 31(10):949-51. PubMed ID: 711618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subsequent mutagenesis under the action of UV rays in a culture of Actinomadura carminata, a producer of carminomycin].
    Lapchinskaia OA; Saburova TP; Filicheva VA; L'vova NA
    Antibiotiki; 1976 Sep; 21(9):791-5. PubMed ID: 999262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei.
    Jin ZH; Lin JP; Cen PL
    J Zhejiang Univ Sci; 2004 Dec; 5(12):1590-6. PubMed ID: 15547969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arthrobacter simplex var. amylolyticus var. nov., a producer of a hexaene antibiotic in the fradicin-mycelin group].
    Kuznetsova OS; Kruglikova LF; Konev IuE; Shenin IuD; Turkevich GB
    Antibiotiki; 1980 Feb; 25(2):83-8. PubMed ID: 7356309
    [No Abstract]   [Full Text] [Related]  

  • 19. [Production of rifamycin complex].
    Oner M; Tamer AU; Bursalioğlu M
    Mikrobiyol Bul; 1987 Oct; 21(4):296-300. PubMed ID: 3503969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial transformation of rifamycin B: a new synthetic approach to rifamycin derivatives.
    Seong BL; Son HJ; Mheen TI; Han MH
    J Antibiot (Tokyo); 1983 Oct; 36(10):1402-4. PubMed ID: 6685721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.